⌘K

Login Start Free

Home/Filings/4/0001628280-24-001842

4//SEC Filing

Morberg John D 4

Accession 0001628280-24-001842

CIK 0001005286other

View on SEC.gov Company Profile

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 2:26 PM ET

Size

8.3 KB

Accession

0001628280-24-001842

Insider Transaction Report

Form 4

Period: 2024-01-18

LIFECORE BIOMEDICAL, INC. \DE\LFCR

Chief Financial Officer

Transactions

Tax Payment
Common Stock
2024-01-18−6,283→ 125,617 total
Exercise/Conversion
Restricted Stock Unit
2024-01-18−17,500→ 0 total
From: 2024-01-18→ Common Stock (17,500 underlying)
Exercise/Conversion
Common Stock
2024-01-18+17,500→ 131,900 total

Footnotes (2)

[F1]The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
[F2]The restricted stock units vested on January 18, 2024.

Documents

1 file

4
wk-form4_1705951591.xmlPrimary
FORM 4

Issuer

LIFECORE BIOMEDICAL, INC. \DE\

CIK 0001005286

Entity typeother

Related Parties

1

filerCIK 0001345964

Filing Metadata

Form type: 4
Filed: Jan 21, 7:00 PM ET
Accepted: Jan 22, 2:26 PM ET
Size: 8.3 KB

View on SEC.gov